Penserra Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,580
| Closed | -$5K | – | 1595 |
|
|
2021
Q3 | $5K | Buy |
1,580
+10
| +0.6% | +$32 | ﹤0.01% | 1414 |
|
|
2021
Q2 | $6K | Sell |
1,570
-25
| -2% | -$96 | ﹤0.01% | 1313 |
|
|
2021
Q1 | $7K | Buy |
1,595
+15
| +0.9% | +$66 | ﹤0.01% | 1066 |
|
|
2020
Q4 | $9K | Buy |
1,580
+994
| +170% | +$5.66K | ﹤0.01% | 938 |
|
|
2020
Q3 | $4K | Buy |
+586
| New | +$4K | ﹤0.01% | 875 |
|